AscellaHealth Service and Infrastructure Enhancements Support Specialty Drug Manufacturers to Protect Market Share Across Brand, Biosimilar and Generic Launches

BERWYN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces service and infrastructure enhancements designed to help specialty and rare disease drug manufacturers respond to accelerating market disruption across the pharmaceutical landscape. From sudden formulary exclusions and loss of preferred status to the growing impact of biosimilars, generics and aggressive cost-containment measures by payers, manufacturers rely upon a strategic, flexible distribution partnership with AscellaHealth.

To read more, click here